OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ARMP

Stock ticker: ASE

PRICE

CHANGE

CAPITALIZATION

Armata Pharmaceuticals (ARMP) Earnings Date & Reports

Armata Pharmaceuticals Inc is a developer of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using its proprietary bacteriophage-based technology... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

ARMP is expected to report earnings to rise 11.11% to -50 cents per share on November 12

Armata Pharmaceuticals ARMP Stock Earnings Reports

Q3'25

Est.

$-0.50

Q2'25

Missed

by $0.06

Q1'25

Missed

by $0.04

Q4'24

Beat

by $0.06

Q3'24

Beat

by $0.13

The last earnings report on August 12 showed earnings per share of -44 cents, missing the estimate of -38 cents. With 3.88K shares outstanding, the current market capitalization sits at 91.57M.

View a ticker or compare two or three

Compare

ARMP

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ARMP
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ARMP showed earnings on August 12, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of novel bacteriophage-based therapeutics

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

5005 McConnell Avenue

Phone

+1 310 665-2928

Employees

Web

https://www.armatapharma.com